Crippling SARS-CoV-2 vaccine supply crunch, vaccination target and scope in Bangladesh

• The global demand for COVID-19 vaccines continues to outpace the supply. • Millions of additional vaccine doses are already being stored in wealthy nations for future use. • Currently, the most crucial challenge is a race between virus spread and vaccination. • Bangladesh plans to vaccinate 80% of...

Descripción completa

Detalles Bibliográficos
Autores principales: Islam, Md. Samiul, Parvin, Sultana, Al Mamun, Md Bahauddin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496918/
https://www.ncbi.nlm.nih.gov/pubmed/34642659
http://dx.doi.org/10.1016/j.hpopen.2021.100054
_version_ 1784579851570642944
author Islam, Md. Samiul
Parvin, Sultana
Al Mamun, Md Bahauddin
author_facet Islam, Md. Samiul
Parvin, Sultana
Al Mamun, Md Bahauddin
author_sort Islam, Md. Samiul
collection PubMed
description • The global demand for COVID-19 vaccines continues to outpace the supply. • Millions of additional vaccine doses are already being stored in wealthy nations for future use. • Currently, the most crucial challenge is a race between virus spread and vaccination. • Bangladesh plans to vaccinate 80% of its people by 2022, with most vaccines coming from outside. • Without local production, it would be a big issue; co-production of vaccines might be the best solution.
format Online
Article
Text
id pubmed-8496918
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84969182021-10-08 Crippling SARS-CoV-2 vaccine supply crunch, vaccination target and scope in Bangladesh Islam, Md. Samiul Parvin, Sultana Al Mamun, Md Bahauddin Health Policy Open Letters to the Editor • The global demand for COVID-19 vaccines continues to outpace the supply. • Millions of additional vaccine doses are already being stored in wealthy nations for future use. • Currently, the most crucial challenge is a race between virus spread and vaccination. • Bangladesh plans to vaccinate 80% of its people by 2022, with most vaccines coming from outside. • Without local production, it would be a big issue; co-production of vaccines might be the best solution. Elsevier 2021-10-07 /pmc/articles/PMC8496918/ /pubmed/34642659 http://dx.doi.org/10.1016/j.hpopen.2021.100054 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letters to the Editor
Islam, Md. Samiul
Parvin, Sultana
Al Mamun, Md Bahauddin
Crippling SARS-CoV-2 vaccine supply crunch, vaccination target and scope in Bangladesh
title Crippling SARS-CoV-2 vaccine supply crunch, vaccination target and scope in Bangladesh
title_full Crippling SARS-CoV-2 vaccine supply crunch, vaccination target and scope in Bangladesh
title_fullStr Crippling SARS-CoV-2 vaccine supply crunch, vaccination target and scope in Bangladesh
title_full_unstemmed Crippling SARS-CoV-2 vaccine supply crunch, vaccination target and scope in Bangladesh
title_short Crippling SARS-CoV-2 vaccine supply crunch, vaccination target and scope in Bangladesh
title_sort crippling sars-cov-2 vaccine supply crunch, vaccination target and scope in bangladesh
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496918/
https://www.ncbi.nlm.nih.gov/pubmed/34642659
http://dx.doi.org/10.1016/j.hpopen.2021.100054
work_keys_str_mv AT islammdsamiul cripplingsarscov2vaccinesupplycrunchvaccinationtargetandscopeinbangladesh
AT parvinsultana cripplingsarscov2vaccinesupplycrunchvaccinationtargetandscopeinbangladesh
AT almamunmdbahauddin cripplingsarscov2vaccinesupplycrunchvaccinationtargetandscopeinbangladesh

Ejemplares similares